A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity

NCT06041841 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

POMC Deficiency Obesity
PCSK1 Deficiency Obesity
LEPR Deficiency Obesity

Interventions

DRUG: LB54640

Sponsor

LG Chem